英国与爱尔兰乳腺保乳手术切缘实践及对再切除率的影响:2858例全国前瞻性研究
该前瞻性多中心研究于2016年2月1日至5月31日在英国和爱尔兰79家单位纳入2858例保乳患者,描述切缘政策与基础设施对再切除率的影响。各单位平均再切除率为17.2%(范围0-41%),若全部采用SSO-ASTRO或ABS指南,再切除率将分别降至15%和14.8%。大多数再手术(65%)是因切缘阳性而非切缘过近。
要点
- 各单位切缘政策差异大:DCIS中53.2%接受1 mm、38%接受2 mm;浸润癌中77.2%接受1 mm、13.9%接受「无墨染」。
- 2858例保乳患者各单位平均再切除率为17.2%(范围0-41%)。
- 若全部采用SSO-ASTRO指南,再切除率降至15%;若全部采用ABS指南,降至14.8%。
核心结论
- 各单位切缘政策与再切除率仍存在很大差异。
- 将切缘政策改为遵循SSO-ASTRO或ABS指南会使全国再切除率适度降低。
- 多数再切除是针对切缘阳性而非切缘过近。
研究设计与样本
- 由培训生协作组牵头的前瞻性多中心研究,于2016年2月1日至5月31日在英国和爱尔兰开展。
- 共79家单位参与数据收集,其中75%为筛查单位,年平均癌症量372例(范围70-900例)。
- 连续纳入接受保乳治疗的2858例患者,并收集当地基础设施与政策数据。
主要发现
- 对于DCIS,53.2%的单位接受1 mm切缘,38%接受2 mm切缘。
- 对于浸润性疾病,77.2%的单位接受1 mm切缘,13.9%接受「无墨染」。
- 2858例患者接受保乳治疗,各单位平均再切除率为17.2%(范围0-41%)。
- 若所有单位应用SSO-ASTRO指南,再切除率将降至15%;若遵循ABS指南,将降至14.8%。
- 在需要再手术的患者中,65%切缘存在病变。
关键数值与推荐
- SSO-ASTRO共识:浸润癌「无墨染」,导管原位癌2 mm。
- ABS共识:浸润癌和导管原位癌均为1 mm。
- DCIS切缘接受度:53.2%单位接受1 mm,38%接受2 mm。
- 浸润性疾病切缘接受度:77.2%单位接受1 mm,13.9%接受「无墨染」。
- 再切除率:各单位平均17.2%(范围0-41%),若全部采用SSO-ASTRO降至15%,若全部采用ABS降至14.8%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: There is variation in margin policy for breast conserving therapy (BCT) in the UK and Ireland. In response to the Society of Surgical Oncology and American Society for Radiation Oncology (SSO-ASTRO) margin consensus ('no ink on tumour' for invasive and 2 mm for ductal carcinoma in situ [DCIS]) and the Association of Breast Surgery (ABS) consensus (1 mm for invasive and DCIS), we report on current margin practice and unit infrastructure in the UK and Ireland and describe how these factors impact on re-excision rates. METHODS: A trainee collaborative-led multicentre prospective study was conducted in the UK and Ireland between 1st February and 31st May 2016. Data were collected on consecutive BCT patients and on local infrastructure and policies. RESULTS: A total of 79 sites participated in the data collection (75% screening units; average 372 cancers annually, range 70-900). For DCIS, 53.2% of units accept 1 mm and 38% accept 2-mm margins. For invasive disease 77.2% accept 1 mm and 13.9% accept 'no ink on tumour'. A total of 2858 patients underwent BCT with a mean re-excision rate of 17.2% across units (range 0-41%). The re-excision rate would be reduced to 15% if all units applied SSO-ASTRO guidelines and to 14.8% if all units followed ABS guidelines. Of those who required re-operation, 65% had disease present at margin. CONCLUSION: There continues to be large variation in margin policy and re-excision rates across units. Altering margin policies to follow either SSO-ASTRO or ABS guidelines would result in a modest reduction in the national re-excision rate. Most re-excisions are for involved margins rather than close margins.
引用
- Tang SS, Kaptanis S, Haddow JB, et al. Current margin practice and effect on re-excision rates following the publication of the SSO-ASTRO consensus and ABS consensus guidelines: a national prospective study of 2858 women undergoing breast-conserving therapy in the UK and Ireland. Eur J Cancer. 2017. PMID: 28865259. doi:10.1016/j.ejca.2017.07.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。